---
$id: https://graph.org.ai/products/commodity/51171979
$type: Product
source: UNSPSC
code: "51171979"
title: "Sacrosidase"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sacrosidase

**UNSPSC Code**: 51171979
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a glycoside hydrolase found primarily in plants and yeasts, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8A7F670F2Y, chemically known as .beta.-fructofuranosidase but generally known as Sacrosidase. European Medicines Agency schedules Sacrosidase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB38353. World Health Organization schedules bismuth subcitrate in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, SACROSIDASE remains the US FDA Preferred Term for this commodity.

